title: Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?
authors.affiliation: Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands m.valgimigli@erasmusmc.nl.
authors.forename: Marco
authors.initials: M
authors.lastname: Valgimigli
authors.affiliation: Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Sara
authors.initials: S
authors.lastname: Ariotti
authors.affiliation: Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Francesco
authors.initials: F
authors.lastname: Costa
mesh_terms: D003324:Coronary Artery Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine